Scientific Opinion on the substantiation of health claims related to alpha cylcodextrin and reduction of post prandial glycaemic responses (ID 856, 2926), maintenance or achievement of a normal body weight (ID 2925) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

EFSA Journal

Volumn 8, Issue 2, 2010, Pages

[No Author Info available]

Author keywords

Alpha cyclodextrin; body weight; glycaemic response; health claims

Indexed keywords

EID: 85078377947     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2010.1479     Document Type: Article

References (4)

1. Artiss JD, Brogan K, Brucal M, Moghaddam M and Jen KL, 2006. The effects of a new soluble dietary fiber on weight gain and selected blood parameters in rats. Metabolism, 55, 195–202.
2. Buckley JD, Thorp AA, Murphy KJ and Howe PR, 2006. Dose-dependent inhibition of the postprandial glycaemic response to a standard carbohydrate meal following incorporation of alpha-cyclodextrin. Annals of Nutrition and Metabolism, 50, 108–114.
3. Grunberger G, Jen KL and Artiss JD, 2007. The benefits of early intervention in obese diabetic patients with FBCx: a new dietary fibre. Diabetes/Metabolism Research and Reviews, 23, 56–62.
4. Venn BJ and Green TJ, 2007. Glycemic index and glycemic load: measurement issues and their effect on diet-disease relationships. European Journal of Clinical Nutrition, 61, 122–131.